Showing 11,541 - 11,560 results of 18,566 for search 'significantly ((((((we decrease) OR (linear decrease))) OR (a decrease))) OR (mean decrease))', query time: 0.66s Refine Results
  1. 11541
  2. 11542

    Effects of βHB treatment on edema and NDS 3 days after ICH. by Noam H. Sander (13977976)

    Published 2024
    “…<p>A) In experiment 2, body weight was decreased on day 1 after ICH (p<0.0001), but not different between treatment groups at all times assessed (all p≥0.2118). …”
  3. 11543

    Raw data_clean. by Carlos Sepúlveda (15272797)

    Published 2025
    “…Maximal oxygen consumption and ventilatory thresholds were measured using a modified Balke protocol. After initial screening, all participants performed an exercise task that involved stepping up and down on a 2-step footstool at a rate of 30 steps per minute (60 bpm) for 3 minutes.…”
  4. 11544

    Experimental design. by Carlos Sepúlveda (15272797)

    Published 2025
    “…Maximal oxygen consumption and ventilatory thresholds were measured using a modified Balke protocol. After initial screening, all participants performed an exercise task that involved stepping up and down on a 2-step footstool at a rate of 30 steps per minute (60 bpm) for 3 minutes.…”
  5. 11545

    Characterization of the participants. by Carlos Sepúlveda (15272797)

    Published 2025
    “…Maximal oxygen consumption and ventilatory thresholds were measured using a modified Balke protocol. After initial screening, all participants performed an exercise task that involved stepping up and down on a 2-step footstool at a rate of 30 steps per minute (60 bpm) for 3 minutes.…”
  6. 11546
  7. 11547

    Initial assessment of βHB treatment effects. by Noam H. Sander (13977976)

    Published 2024
    “…<p>A) In experiment 1, body weight was reduced on day 1 after ICH (day 1, p<0.0001), and the βHB group weighed more than the VEH group on day 1 (p = 0.0250). …”
  8. 11548

    <i>SEL1L</i> variants affect proteasome inhibition sensitivity. by Travis K. Tu’ifua (22008843)

    Published 2025
    “…<b>(B)</b> When treated with 1μM BTZ, the <i>NGLY1 + /-</i> larvae show a <i>SEL1L</i> genotype-dependent decrease in size. …”
  9. 11549

    <b>Role of the Chaperone ClpB in</b><b> </b><b>Mycoplasma bovis</b><b> Virulence: Implications for </b><b>stress response, a</b><b>dhesion, </b><b>b</b><b>iofilm </b><b>d</b><b>eve... by Hui zhang (22187170)

    Published 2025
    “…Despite its well-conserved function in prokaryotes, the specific contributions of ClpB to the pathogenesis of the ruminant pathogen Mycoplasma bovis remain largely unexplored. In this study, we identified and functionally characterized a ClpB homolog in M. bovis. …”
  10. 11550

    Trial design. by Llum Páez (22553360)

    Published 2025
    “…Regarding efficacy, Neoleish vaccine affected the progression of parasite multiplication in bone marrow and peripheral blood, showing a statistically significant reduction of parasite load in vaccinated animals at the end of the study. …”
  11. 11551

    Schedule of the trial. by Llum Páez (22553360)

    Published 2025
    “…Regarding efficacy, Neoleish vaccine affected the progression of parasite multiplication in bone marrow and peripheral blood, showing a statistically significant reduction of parasite load in vaccinated animals at the end of the study. …”
  12. 11552

    Clinical symptoms scoring system. by Llum Páez (22553360)

    Published 2025
    “…Regarding efficacy, Neoleish vaccine affected the progression of parasite multiplication in bone marrow and peripheral blood, showing a statistically significant reduction of parasite load in vaccinated animals at the end of the study. …”
  13. 11553

    Marketed vaccines against canine leishmaniasis. by Llum Páez (22553360)

    Published 2025
    “…Regarding efficacy, Neoleish vaccine affected the progression of parasite multiplication in bone marrow and peripheral blood, showing a statistically significant reduction of parasite load in vaccinated animals at the end of the study. …”
  14. 11554

    Bone-related serum chemistry endpoints: Aquamin (180-day treatment group) versus placebo. by Muhammad N. Aslam (6598001)

    Published 2025
    “…<p>A. Serum osteocalcin: Values (ng/mL). B. Serum TRAP5b: Values (mIU/mL). …”
  15. 11555

    Biochemical data. by Abdallah Tageldein Mansour (21158819)

    Published 2025
    “…The colitic group showed a significant increase (P < 0.05) in C-reactive protein (CRP) and myeloperoxidase (MPO) and nitric oxide (NO) (35.60, 163.30 and 280 nmol/g tissue respectively) and higher expression (P < 0.05) <i>IL-17</i>, <i>TNF-α</i>, and <i>IL-1β</i> (increased up to 2.99, 4.36 and 4.90 respectively unlike PPE-NPsIII that recorded reduced levels of CRP, MPO and NO (8,96, 78.30 and 123 nmol/g tissue respectively) and much lower (P < 0.05) levels of IL-17, TNF-α, and IL-1β expression (decreased to 1.23, 1.69 and 1.64, respectively). …”
  16. 11556

    Scoring of Disease Activity Index (DAI). by Abdallah Tageldein Mansour (21158819)

    Published 2025
    “…The colitic group showed a significant increase (P < 0.05) in C-reactive protein (CRP) and myeloperoxidase (MPO) and nitric oxide (NO) (35.60, 163.30 and 280 nmol/g tissue respectively) and higher expression (P < 0.05) <i>IL-17</i>, <i>TNF-α</i>, and <i>IL-1β</i> (increased up to 2.99, 4.36 and 4.90 respectively unlike PPE-NPsIII that recorded reduced levels of CRP, MPO and NO (8,96, 78.30 and 123 nmol/g tissue respectively) and much lower (P < 0.05) levels of IL-17, TNF-α, and IL-1β expression (decreased to 1.23, 1.69 and 1.64, respectively). …”
  17. 11557

    Primers sequences used in this study. by Abdallah Tageldein Mansour (21158819)

    Published 2025
    “…The colitic group showed a significant increase (P < 0.05) in C-reactive protein (CRP) and myeloperoxidase (MPO) and nitric oxide (NO) (35.60, 163.30 and 280 nmol/g tissue respectively) and higher expression (P < 0.05) <i>IL-17</i>, <i>TNF-α</i>, and <i>IL-1β</i> (increased up to 2.99, 4.36 and 4.90 respectively unlike PPE-NPsIII that recorded reduced levels of CRP, MPO and NO (8,96, 78.30 and 123 nmol/g tissue respectively) and much lower (P < 0.05) levels of IL-17, TNF-α, and IL-1β expression (decreased to 1.23, 1.69 and 1.64, respectively). …”
  18. 11558
  19. 11559

    Experimental procedures. by Ellen Chan (22177558)

    Published 2025
    “…Comparisons of back pain intensity, ratio of the normalized electromyography (EMG) of the paired lumbopelvic muscles during walking, and performance of the lumbar movement control tests (LMC) using inferential statistics to analyze between- and within-subject effects differences for the a) real-time and b) immediate effects of the single session of walking training designated in a backward direction as compared to forward direction.…”
  20. 11560

    Experimental procedures. by Ellen Chan (22177558)

    Published 2025
    “…Comparisons of back pain intensity, ratio of the normalized electromyography (EMG) of the paired lumbopelvic muscles during walking, and performance of the lumbar movement control tests (LMC) using inferential statistics to analyze between- and within-subject effects differences for the a) real-time and b) immediate effects of the single session of walking training designated in a backward direction as compared to forward direction.…”